Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1946 1
1947 1
1968 1
1970 1
1975 3
1976 3
1977 4
1978 3
1979 4
1980 2
1981 2
1982 2
1983 5
1984 2
1985 2
1986 1
1987 5
1988 1
1989 8
1990 6
1991 3
1992 7
1993 2
1994 7
1995 12
1996 8
1997 11
1998 10
1999 10
2000 27
2001 26
2002 28
2003 36
2004 46
2005 36
2006 39
2007 33
2008 44
2009 40
2010 52
2011 38
2012 44
2013 45
2014 36
2015 35
2016 48
2017 36
2018 34
2019 39
2020 33
2021 33
2022 31
2023 38
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

939 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: bird s. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
Makker V, Colombo N, Casado Herráez A, Monk BJ, Mackay H, Santin AD, Miller DS, Moore RG, Baron-Hay S, Ray-Coquard I, Ushijima K, Yonemori K, Kim YM, Guerra Alia EM, Sanli UA, Bird S, Orlowski R, McKenzie J, Okpara C, Barresi G, Lorusso D. Makker V, et al. Among authors: bird s. J Clin Oncol. 2023 Jun 1;41(16):2904-2910. doi: 10.1200/JCO.22.02152. Epub 2023 Apr 14. J Clin Oncol. 2023. PMID: 37058687 Free PMC article. Clinical Trial.
Acute Manifestations of Neuromuscular Disease.
Edmundson C, Bird SJ. Edmundson C, et al. Among authors: bird sj. Semin Neurol. 2019 Feb;39(1):115-124. doi: 10.1055/s-0038-1676838. Epub 2019 Feb 11. Semin Neurol. 2019. PMID: 30743297 Review.
Multiple myeloma: an overview of management.
Bird SA, Boyd K. Bird SA, et al. Palliat Care Soc Pract. 2019 Oct 9;13:1178224219868235. doi: 10.1177/1178224219868235. eCollection 2019. Palliat Care Soc Pract. 2019. PMID: 32215370 Free PMC article. Review.
Artificial placenta: Analysis of recent progress.
Bird SD. Bird SD. Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:61-70. doi: 10.1016/j.ejogrb.2016.11.005. Epub 2016 Nov 11. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 27894031 Review.
Scotland's National Naloxone Programme.
Bird SM, McAuley A. Bird SM, et al. Lancet. 2019 Jan 26;393(10169):316-318. doi: 10.1016/S0140-6736(18)33065-4. Lancet. 2019. PMID: 30696566 No abstract available.
939 results